Today, @contraline Inc and the Population Council announced they have executed a global, exclusive license agreement for the Nestorone®/Testosterone (NES/T) male contraceptive gel.
Read our press release: bit.ly/3Zdr3Mt
3/ The worst part is that Wired used to be filled with incredible pieces that framed my thinking around the future, like this one from April 2011 about new birth control methods for men that eventually led (nearly a decade later) to @foundersfund making an investment in a company commercializing the tech @contraline.
wired.com/2011/04/ff-vasecto…
Great article by @JessGrose in @nytimes. Previously, male contraception faced skepticism, with concerns about trust in men's proper use and motivation, but new developments are emerging. It's time for new options!
nytimes.com/2023/11/08/opini…
We are proud to announce the successful launch of two new sites in Australia for “The ADAM Study,” its First-in-Human clinical trial studying the safety of ADAM, a hydrogel-based, long-lasting, non-hormonal, and non-permanent male contraceptive.
einpresswire.com/article/665…
At Contraline, we really believe in the power of a shared passion. When you bring on team members that authentically embrace your mission, you'll see results. Thank you Katie for all your hard work. We are lucky to have you on our team!
#team#startup#employerbranding#employee
Can you believe there haven't been any major developments in male contraception since 1897? Yes, you read that right....1897 was when the first vasectomy was performed.
Who thinks it's time for the next major development in male contraception?
#malecontraception#WomensHealth
We are so proud to see our story picked up nationally after @DrydenQuigley. Quigley came by our new office to talk about male contraceptives and the impact Contraline can make. It's so exciting to see interest beyond our local news for this important milestone for contraceptives.
During the twentieth century, women’s education levels continuously increased, and in most high-income countries they are now substantially higher than for men. Claudia Goldin – awarded the 2023 prize in economic sciences – demonstrated that access to the contraceptive pill played an important role in accelerating this revolutionary change by offering new opportunities for career planning.
#NobelPrize
IUDs…but for men. That’s the idea behind one Charlottesville/UVA grad company. The goal is for this to be the new norm in as soon as 4 years @contraline@NBC29@UVA
Have you met our CTO Yelena Tropsha, PhD? At Contraline, Dr. Tropsha leads all R&D, regulatory affairs, and reimbursement efforts.
We are grateful to have you on our team Yelena! Thank you for all the great work you do.
#menshealth#womenshealth#scientist#urology#gynecology
We are proud to have Martin Varsavsky and his team at Myelin VC alongside us on our journey to create a new future of male contraception.
Thank you Martin and team for your invaluable guidance and support.
#fertility#malecontraception#womenshealth#menshealth#birthcontrol